Celebrating a year of community engagement

February 24, 2024 Providence Cancer Institute of Oregon

At Providence Cancer Institute of Oregon, we surround our patients with cutting-edge treatments and compassionate support, and we work closely with community partners to improve access to health care across the communities we serve.

This is especially important for underserved and vulnerable communities who have difficulty accessing health care services due to financial challenges, language barriers or lack of transportation resources. As a Mission-driven health care organization and an accredited program of the American College of Surgeons' Commision on Cancer, we are committed to improving the health of our communities and ending cancer health disparities.

In 2022, we were proud to have sponsored and participated in 25 community events held virtually and in-person: 1 cancer screening event, 10 educational talks and 14 community engagement events.

“Community partnerships raise awareness about the symptoms and risk factors associated with cancer and how people can reduce their risk through screening and prevention,” said Lyn Burrell Dobrunick, MN, FNP, executive director, Providence Cancer Institute of Oregon. “They also provide vital resources to patients and families in need of extra support throughout their cancer journey.”

Providence oncology nurse navigators, oncology social workers and resource specialists worked closely with patients to provide financial assistance resources through community partner grants and donations. Patients also received educational and support group resources made available by our cancer control and education team. These benefits are in addition to the financial, psychological and social support resources provided by Providence as part of our Mission to care for the poor and vulnerable.

Collaborating with diverse community groups

Patient education is an important part of the cancer journey. For diverse communities, however, time constraints, communication obstacles and cultural differences can create barriers to education.

To support patients from different backgrounds, our cancer control and education team creates education materials and videos developed with patient-friendly medical information and health literacy principles. They are available in Spanish, Russian, Chinese and other languages and are important resources for our community partnerships with underserved populations.

We partnered with and supported Promotores de Salud (a program of Providence Community Health Division) and Providence Newberg Medical Center Diagnostic Imaging to provide free mammograms for Latina women. The goal of the screening event was early detection of breast cancer, the leading cause of cancer death among U.S. Hispanic women. However, when breast cancer is caught at its earliest most treatable stages through preventive screening, women have better health outcomes.

We also partnered with the Asian Health & Service Center (AHSC) for a series of virtual education talks featuring our experts in colorectal cancer, lymphoma, nutrition and integrative medicine. We have established a strong relationship with AHSC to support our Chinese, Korean and Vietnamese communities.

Engaging our patients in their health care

Our patient-centered approach to care brings together the best cancer treatments with unsurpassed support and service. In collaboration with our cancer control, education and resource specialist teams, Providence cancer experts led several patient education talks and panel discussions on the latest treatments, research and clinical trials for gynecologic, pancreatic, skin and blood cancers. Other topics included integrative medicine and oncology nurse navigation, social work and nutrition.

View full presentation here.

Supporting our community

Being active participants in run/walk events and fundraising campaigns throughout Oregon is an important part of supporting our patients and their family members. We were proud to sponsor a range of fun and important events this year: Get Your Rear in Gear, Hood to Coast/PDX to Coast Relays, Hope Gala, Kite Board4Cancer, Light the Night, Making Strides Against Breast Cancer, O’Vary Funny, Pink Glow Gala, PurpleStride, Reach the Beach, Relay for Life Yamhill County, Steps Against Melanoma, #TurquoiseTakeover, and Zero Prostate Cancer Run/Walk.

Of special note, our own Janet Ruzich, D.O., was honored as the 2022 Woman of the Year for Portland by the Leukemia & Lymphoma Society, for her fundraising efforts to support blood cancer research in our community.

Grateful for our partnerships

Thank you to all our 2022 partner organizations:

We look forward to presenting new patient education events in 2023 and continuing to support the communities we are honored to serve.

To learn more about our support services and resources for patients, visit Providence.org/ORcancersupport.

For the latest news on community and patient education events, be sure to follow us on Facebook, Twitter and Linkedin.

Medical expert shares promising treatments and latest research for gynecologic cancers

Providence oncologist named 2022 Woman of the Year

Welcome to your journey for creating a healthier you

Celebrating a year of community engagement

Previous Article

Next Article

Celebrating a year of community engagement

Previous Article

Next Article

Other content in this Stream

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Cancer survivor Mark Williams chats with Dr. Brendan Curti about

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

The radiation oncology team at Joe Arrington Cancer Center is awarded APEx Accreditation for excellent care.

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Patient Navigators provide a wealth of information and support to patients and families at all three Providence oncology locations: Lacey, Centralia and Aberdeen.